INS and diabetes mellitus: Our findings, in the present study, of significant and superior actions of the triple drug combination of GABA, a DPP-4i and a PPI (A+B+C) to increase C-peptide and insulin levels, compared with the double drug combinations, both in diabetes prevention and reversal, supports the conclusion that the triple therapy improved diabetes by actions leading to improved islet β-cell function.